Internal Medicine, Rheumatology · Sacramento, CA
NPI
1033287545
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
107 Scripps Dr, #100
Sacramento, CA, 95825
Phone (916) 922-7021
Groups this clinician bills Medicare through
Medicare paid, 2024
$212K
2,436 services
Medicare patients, 2024
801
Average age 75
Drug cost, 2024
$5.6M
9,139 prescriptions
Company payments, 2025
$128
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kenneth B Wiesner was code 99214 (office e&m - established), 1,762 times for 742 patients. In total Kenneth B Wiesner billed 2,436 services in 12 codes, and Medicare paid $212K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,762 | 742 | $102.01 | $180K |
| 99213 Office E&M - Established | Office | 314 | 203 | $72.43 | $23K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 187 | 27 | $0.73 | $137 |
| 20610 Joint Injection | Office | 31 | 23 | $53.10 | $1,646 |
| 99204 Office E&M - New | Office | 22 | 22 | $132.71 | $2,920 |
By year: 2022 $184K for 2,480 services; 2023 $191K for 2,498 services; 2024 $212K for 2,436 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kenneth B Wiesner prescribed most often to Medicare patients was Prednisone, with 1,299 prescriptions and refills. In total Kenneth B Wiesner wrote 9,139 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,299 | 2,260 | 290 | $18K |
| Methotrexate Methotrexate Sodium | 990 | 2,057 | 236 | $21K |
| Hydroxychloroquine Sulfate Generic | 700 | 1,421 | 173 | $30K |
| Tramadol Hcl Generic | 638 | 638 | 115 | $8,192 |
| Leucovorin Calcium Generic | 451 | 1,042 | 120 | $9,992 |
| Colchicine Generic | 279 | 652 | 86 | $19K |
| Allopurinol Generic | 249 | 656 | 70 | $4,599 |
| Atorvastatin Calcium Generic | 239 | 577 | 59 | $2,157 |
| Celecoxib Generic | 188 | 438 | 52 | $12K |
| Folic Acid Generic | 163 | 390 | 42 | $1,661 |
| Enbrel Etanercept | 149 | 163 | 18 | $1.2M |
| Gabapentin Generic | 146 | 286 | 43 | $2,283 |
| Enbrel Sureclick Etanercept | 140 | 150 | 16 | $1.1M |
| Temazepam Generic | 129 | 141 | 16 | $1,935 |
| Mycophenolate Mofetil Generic | 124 | 202 | 26 | $15K |
Brand drugs: 947 claims; generic drugs: 8,125 claims; opioid claims: 936.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kenneth B Wiesner $128 ($128 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $128.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.